The RWJF story is told through the eyes and voices of:
* Robert E. Campbell, M.B.A., retired vice chairman of Johnson & Johnson, former chairman of the Board of Trustees of the Robert Wood Johnson Foundation
* Susan Dentzer, editor-in-chief, Health Affairs
* Risa Lavizzo-Mourey, M.D., M.B.A., RWJF president and CEO
* Ramanan Laxminarayan, Ph.D., senior fellow, Resources for the Future
Ramanan Laxminarayan and Ed Septimus explain that controlling hospital acquired infections should be part of any health reform proposal that aims to reduce costs without sacrificing quality. In fact, infection control saves lives. Read their op-ed to Roll Call.
Health Reform Should Tackle the Rising Threat of Hospital Infections June 30, 2009, 2:50 p.m.
By Ramanan Laxminarayan and Ed Septimus, Special to Roll Call
In an op-ed in today’s Chicago Tribune, ETC researchers Anup Malani and Ramanan Laxminarayan urge state and federal policymakers to get tough on bacterial and especially antibiotic resistant infections. They note the high costs of these infections—both in terms of lives and dollars—and remind us that a flu pandemic could be made worse by co-infection.
Beyond swine flu: Superbugs
The $50 million in stimulus money marked for prevention of healthcare associated infections should be used to help hospitals communicate as to which patients are colonized with resistant bacteria. This communication is especially important in a state like Florida. With so much traffic in and out of the state, Florida is uniquely poised to affect infection rates far beyond its borders. Read the ETC op-ed in the St. Petersburg Times.
ETC researcher Ramanan Laxminarayan and Eli Perencevich, Medical Director for Infection Control at the University of Maryland Medical Center, are published in today's Baltimore Sun advocating a regional approach to infection control in healthcare settings among other incentive based policies.
Getting Ahead of the Superbugs: HHS must think outside the hospital box to combat this threat to public health on a regional scale
The following letter from ETC was published in Today's Modern Healthcare:
On August 11, 2008, The New Yorker included a feature piece on antibiotic-resistant infections.
“The article “Study shows staph infections related to hospital understaffing,” (June 25, 2008) describes findings from a recent study on how overcrowding and understaffing contribute to the spread of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals. We would point out two important considerations in how to address this growing problem.
On April 28-29, 2008, Extending the Cure convened a group of 30 healthcare professionals—practicing physicians, healthcare administrators, policy-makers, and academics— to discuss hospital infection control in the context of emerging antibiotic resistance. Some key observations are summarized below:
On April 3, Maryn McKenna cites Ramanan Laxminarayan as he outlines emerging antibiotic resistance as a problem of misaligned incentives and a challenge in resource management. Read the post on her blog Superbug here.
On March 21, the Chicago Tribune published the following letter-to-the-editor by ETC Principal Investigator Anup Malani:
On February 20, ETC Principal Investigators Ramanan Laxminarayan and Anup Malani responded to an LA Times article, “'Superbug' staph reports required", with the following letter-to-the-editor:
Study notes unrelenting growth of staph infections
Staph infections, particularly the methicillin-resistant Staphylococcus aureus strain, are now endemic in hospitals, according to a study to be published in the December issue of Emerging Infectious Diseases. Hospitalizations related to MRSA more than doubled to nearly 280,000 from 127,000 between 1999 and 2005.
The November/December issue of Utne Reader discusses an “Extending the Cure” article from RFF's Resources magazine. The article highlights benefits that antibiotic innovation, education, and regulation could have on minimizing resistance.
The July 23rd edition of Congressional Quarterly's HealthBeat notes the increasing ineffectiveness of antibiotics as discussed in ETC's recent briefings on Capitol Hill. The article references the remarks of ETC's Anup Malani on potential policy responses involving the FDA and Medicare.